Correction to: Acta Pharmacol Sin https://doi.org/10.1038/aps.2017.32, published online 26 June 2017
The authors regret that there were some immunohistochemical figures errors in Fig. 2C and Fig. 6D owing to the mistakes of copying and pasting in the process of assembling figures. In Fig. 2C, the “Trans-SG” group of Ki67 staining is repeated with “LPS + Trans-SG” group in Fig. 2C. In Fig. 6D, the “LPS + Cis-SG + Pioglitazone” group of TUNEL staining is repeated with “Trans-SG” group in Fig. 2D. The “LPS” group of TUNEL staining in Fig. 2D is repeated with “LPS” group in Fig. 6D. All the authors agree on the correction of our negligence, and the correct Fig. 2C “Trans-SG”, Fig. 6D “LPS + Cis-SG + Pioglitazone” and “LPS” groups are provided. The revisions do not affect any results and conclusions of the current work.
The authors apologize for any inconvenience caused to the journal and readers.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Meng, Yk., Li, Cy., Li, Ry. et al. Author Correction: Cis-stilbene glucoside in Polygonum multiflorum induces immunological idiosyncratic hepatotoxicity in LPS-treated rats by suppressing PPAR-γ. Acta Pharmacol Sin 42, 1723–1724 (2021). https://doi.org/10.1038/s41401-020-00592-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41401-020-00592-2